02581 明基醫院
BENQ HOLDING
BENQ HOLDING
| Register Close | 2025/12/17 IPO Closing in 4 Days |
| Listing Date | 2025/12/22 |
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
BenQ BM Holding Cayman Corp. is a private for-profit general hospital group in mainland China, and have adopted the hospital operation and management experiences from Taiwan. The Group currently owns and operates two private for-profit general hospitals. Its revenue derived primarily from the provision of general healthcare services that comprise inpatient healthcare services and outpatient healthcare services.
--
As measured by total revenue in 2024, the Group is the largest private for-profit general hospital group in the East China region, with its market share being 1% in the East China region, according to the report. By the same measure, it is the seventh largest private for-profit general hospital group nationwide, with its market share being 0.4% in the PRC, according to the same source. As measured by average revenue per registered bed in 2024, the Group rank the first among all private for-profit general hospital groups in mainland China, according to the same source.
As of June 30, 2025, the Group’s two hospitals had a total combined GFA of approximately 400,000 sq.m. and 1,850 registered beds, as well as an experienced team featuring more than 1,000 doctors, including 35 experts from Taiwan or overseas. In 2024, the Group recorded over two million outpatient visits and performed over 22,000 inpatient surgeries.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 500 |
GLOBAL OFFERING
| No. of Offer Shares | 67.00M shares |
| No. of International Offer Shares | 60.30M shares |
| No. of HK Offer Shares | 6.70M shares |
| Offer Price | $9.34 - $11.68 |
| Stock Code | 2581 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited, Citigroup Global Markets Asia Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, Citigroup Global Markets Asia Limited, CTBC Bank Co., Ltd., Futu Securities International (Hong Kong) Limited, Livermore Holdings Limited, TradeGo Markets Limited, UOB Kay Hian (Hong Kong) Limited |
TIME TABLE
| Application Period | Dec 12 (Fri) - noon, Dec 17 (Wed) |
| Price Determination Date | Dec 18 (Thu) |
| Result Announcement Date | On or before Dec 19 (Fri) |
| Result Announcement Date | On or before Dec 19 (Fri) |
| Result Announcement Date | On or before Dec 22 (Mon) |
| Dealings in Shares commence on | Dec 22, 2025. (Mon) |
Reallocation of Shares Offered
Sales Statistics (HKD)
| Offer Price | $9.34 - $11.68 |
| Capitalization | 2.91B - 3.64B |
| NAV / share ($) | $7.71 - $8.19 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 10.51, the net proceeds raised would be HKD 626.00M, of which |
| 74.3% : Expansion and upgrade of existing hospitals |
| 16% : Potential investment and mergers and acquisitions opportunities |
| 8% : Fund the upgrade of “Smart Hospital |
| 1.8% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).